Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer [2] (multiple letters)

Kadri Altundag, Ozden Altundag, Paolo Morandi, Mehmet Gunduz, Natasha M. Tiffany, Emily M. Wersinger, Tomasz M. Beer, Mark Garzotto

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)211-212
Number of pages2
JournalUrology
Volume65
Issue number1
DOIs
StatePublished - Jan 2005

ASJC Scopus subject areas

  • Urology

Cite this